A carregar...
Preclinical Cancer Models and Biomarkers for Drug Development: New Technologies and Emerging Tools
BACKGROUND AND PURPOSE: Predicting the efficacy of anticancer therapy is the holy grail of drug development and treatment selection in the clinic. To achieve this goal, scientists require pre-clinical models that can reliably screen anticancer agents with robust clinical correlation. However, there...
Na minha lista:
| Publicado no: | J Mol Biomark Diagn |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5743226/ https://ncbi.nlm.nih.gov/pubmed/29285415 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4172/2155-9929.1000356 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|